All Programs

Use the tool below to view all available Series

From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 program credits
Double-Class Refractory CLL in Community Practice: Current and Future Management
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CE
Double-Class Refractory CLL in Community Practice: Current and Future Management
John C. Byrd, MD; William Mencia, MD, FACEHP
0.25 credits
- John C. Byrd, MD
- William Mencia, MD, FACEHP
0.25 credits
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CE
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Jennifer R. Brown, MD, PhD; William Mencia, MD, FACEHP
0.25 credits
- Jennifer R. Brown, MD, PhD
- William Mencia, MD, FACEHP
0.25 credits
Case Review: Targets Are Met—Can You Stick the Landing? 
Case Review: Targets Are Met—Can You Stick the Landing? 
MinuteCE®
Case Review: Targets Are Met—Can You Stick the Landing? 
David Rubin, MD; Jennifer Geremia, PA-C
1.00 program credit
- David Rubin, MD
- Jennifer Geremia, PA-C
1.00 program credit
Treat-to-Target: Are We There Yet? 
Treat-to-Target: Are We There Yet? 
MinuteCE®
Treat-to-Target: Are We There Yet? 
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
Tailoring Treatment: Can You Select the Best Therapy? 
Tailoring Treatment: Can You Select the Best Therapy? 
MinuteCE®
Tailoring Treatment: Can You Select the Best Therapy? 
David Rubin, MD; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- David Rubin, MD
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
IBD Immunopathogenesis: Do You Know What You're Blocking?
IBD Immunopathogenesis: Do You Know What You're Blocking?
MinuteCE®
IBD Immunopathogenesis: Do You Know What You're Blocking?
Kimberly D. Orleck, PA-C; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- Kimberly D. Orleck, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Switching Strategies: Switch or Stay—What’s Your Call? 
Switching Strategies: Switch or Stay—What’s Your Call? 
MinuteCE®
Switching Strategies: Switch or Stay—What’s Your Call? 
David Rubin, MD; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- David Rubin, MD
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
MinuteCE®
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
MinuteCE®
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Arun B. Jesudian, MD
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
MinuteCE®
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
MinuteCE®
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Hepatic Encephalopathy: More Common Than You Think
Hepatic Encephalopathy: More Common Than You Think
MinuteCE®
Hepatic Encephalopathy: More Common Than You Think
Arun B. Jesudian, MD
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
MinuteCE®
Clearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 credit 9 episodes
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 credit 9 episodes
Precision Treatment Pathways for MDD and Comorbid Insomnia
Precision Treatment Pathways for MDD and Comorbid Insomnia
CME/CE
Precision Treatment Pathways for MDD and Comorbid Insomnia
Michael E. Thase, MD
0.25 credits
- Michael E. Thase, MD
0.25 credits
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CE
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Jose M. Rubio, MD, PhD
0.25 credits
- Jose M. Rubio, MD, PhD
0.25 credits

All Programs

Popular

Title